| # | % | |||||
|---|---|---|---|---|---|---|
| 1 | HERON THERAPEUTICS INC | 4,919,625 | 60,610,000 | 28.07% | ||
| 2 | PDL BIOPHARMA INC | 25,974,000 | 47,866,000 | 22.17% | PRN | |
| 3 | SALIX PHARMACEUTICALS INC | 300,000 | 37,005,000 | 17.14% | ||
| 4 | OPKO Health Inc. | 14,000,000 | 18,739,000 | 8.68% | PRN | |
| 5 | Horizon Pharma Inc | 1,000,000 | 15,820,000 | 7.33% | ||
| 6 | BIOMARIN | 182,300 | 11,341,000 | 5.25% | ||
| 7 | LA JOLLA PHARMACEUTICAL CO | 881,907 | 8,096,000 | 3.75% | ||
| 8 | MERRIMACK PHARMACEUTI | 5,500,000 | 7,490,000 | 3.47% | PRN | |
| 9 | MIRATI THERAPEUTICS INC COM | 288,432 | 5,769,000 | 2.67% | ||
| 10 | ENDOCYTE INC | 465,763 | 3,069,000 | 1.42% | ||
| 11 | Dendreon Corp | 55,548 | 128,000 | 0.06% | ||
| 12 | AMBIT BIOSCIENCES CORP | 46 | 0 | 0.00% |
Portfolio data is normalized using SEC Form 13F filings, including the Original 13F-HR (0001214659-14-005936, filed 2014.08.14).
From 2023-01-03 onward, the SEC requires values to be reported in nearest dollars. Earlier filings reported values in thousands; therefore, positions shown as $0 in older filings may represent actual values between $0–$999.
